Cargando…

An expanded role for blood donor emerging pathogens surveillance

Detalles Bibliográficos
Autores principales:	O’Brien, Sheila F., Goldman, Mindy, Drews, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829065/ https://www.ncbi.nlm.nih.gov/pubmed/36623858 http://dx.doi.org/10.1503/cmaj.147635-l

Ejemplares similares

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance
por: O’Brien, Sheila F., et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
por: O’Brien, Sheila F., et al.
Publicado: (2022)

Tracking SARS-CoV-2 seroprevalence among Canadian blood donors
por: Saeed, Sahar, et al.
Publicado: (2022)

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era
por: Reedman, Cassandra N., et al.
Publicado: (2022)

Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic
por: Drews, Steven J., et al.
Publicado: (2022)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence in the Vaccine Era: The Canadian Blood Services Serosurvey January to November 2021
por: O'Brien, Sheila, et al.
Publicado: (2023)

Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
por: Tuite, Ashleigh R., et al.
Publicado: (2022)

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health
por: O’Brien, Sheila F., et al.
Publicado: (2023)

HCV 6a was expanding and became the predominant subtype among blood donors between 2004 and 2019 in Guangdong, China
por: Du, Rongsong, et al.
Publicado: (2022)

Redefining expanded criteria donor kidneys in the developing world
por: Khan, Taqi T., et al.
Publicado: (2013)

Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors
por: Al-Riyami, Arwa Z., et al.
Publicado: (2019)

A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic
por: Grunau, Brian, et al.
Publicado: (2022)

Zika virus RNA surveillance in blood donors in the Federal District of Brazil during the 2016 outbreak
por: Slavov, Svetoslav Nanev, et al.
Publicado: (2020)

Respiratory virus panels for global surveillance of emerging infectious diseases
por: Brice, Gary T., et al.
Publicado: (2007)

A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
por: Abe, Kento T., et al.
Publicado: (2022)

Metagenomic analysis and identification of emerging pathogens in blood from healthy donors
por: Xu, Min, et al.
Publicado: (2020)

Pooled Testing for Expanding COVID-19 Mass Surveillance
por: Sunjaya, Angela Felicia, et al.
Publicado: (2020)

Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
por: Drews, Steven J., et al.
Publicado: (2021)

Expanding the living renal donor pool by using a horseshoe kidney
por: Kumar, S., et al.
Publicado: (2015)

Putting blood donors at the heart infectious disease surveillance
por: Butler, D, et al.
Publicado: (2023)

Vaccination to blood donors()
por: Rodríguez García, Juan, et al.
Publicado: (2022)

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
por: Lin, Yi-Chan J., et al.
Publicado: (2023)

The estimated risk of SARS-CoV- 2 infection via cornea transplant in Canada
por: O’Brien, Sheila F., et al.
Publicado: (2021)

Surveillance of Transfusion-Transmissible Infections: Comparison of Systems in Five Developed Countries
por: O'Brien, Sheila F., et al.
Publicado: (2012)

Expanding the role of PSMA PET in active surveillance
por: Jain, Anika, et al.
Publicado: (2023)

Donor hemovigilance: Delayed vasovagal reaction with injury in a blood donor
por: Sachdev, Suchet, et al.
Publicado: (2015)

Prevalence of HIV and syphilis among Turkish blood donors
por: Coskun, Omer, et al.
Publicado: (2008)

Frequency of ABO and rhesus blood groups in blood donors
por: Chandra, Tulika, et al.
Publicado: (2012)

Emergency department syndromic surveillance systems: a systematic review
por: Hughes, Helen E., et al.
Publicado: (2020)

Parvovirus 4 in Blood Donors, France
por: Touinssi, Mhammed, et al.
Publicado: (2010)

Blood donor deferrals: Can this be reduced?
por: Jashnani, Kusum D., et al.
Publicado: (2011)

KIs Virus and Blood Donors, France
por: Biagini, Philippe, et al.
Publicado: (2012)

The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid
por: Drews, Steven J.
Publicado: (2016)

The Prevalence of Yersinia Yop-Specific Iga Antibodies in Iranian Healthy Blood Donors and Evaluation of Blood Culture of Seropositive Donors
por: TIMORI NAGHADEH, Hossein, et al.
Publicado: (2016)

Beyond wastewater surveillance: refining environmental pathogen detection in the built environment
por: Abeygunawardena, Sawith, et al.
Publicado: (2022)

Molecular Screening of Blood Donors for Babesia in Tyrol, Austria
por: Bloch, Evan M., et al.
Publicado: (2023)

Insights on 21 Years of HBV Surveillance in Blood Donors in France
por: Cappy, Pierre, et al.
Publicado: (2022)

Parvoviruses in Blood Donors and Transplant Patients, Italy
por: Vallerini, Daniela, et al.
Publicado: (2008)

Hepatitis C Virus in Blood Donors, Brazil
por: Torres, Kátia Luz, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5jlijaib2ikip6i123fs47q7ip